Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 53

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 53
---
-Funded Warrants and Series L Warrants

The following summary of certain terms and provisions of the Pre-Funded Warrants and Series L Warrants offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the form of Pre-Funded Warrant and the form of Series L Warrant, which will be filed as exhibits to the registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions set forth in the form of Series L Warrant and form of Pre-Funded Warrant.

Duration, Exercise Price and Form. The exercise price for the Pre-Funded Warrants is $0.0001 per Depositary Share. The Pre-Funded Warrants are exercisable
at any time after their original issuance until they are exercised in full. Each Series L Warrant will have an initial exercise price
equal to 225% of the public offering price per Unit. The Series L Warrants will be immediately exercisable upon issuance and will expire
two and one-half (2.5) years after the original issuance date. The exercise price and the number of Depositary Shares issuable upon exercise
are subject to adjustment in the event of share dividends, share splits, reorganizations, or similar events affecting our Ordinary Shares
and the exercise price. In addition, at 4:01 p.m. Eastern time on the First Reset Date, the exercise price of the Series L Warrants will
be reset to a price equal to the lower of (i) the exercise price then in effect and (ii) the greater of (a) 80% of lowest daily VWAP during
the period beginning on the 3rd trading day after the date of issuance and ending on the First Reset Date, and (b) 50% of Latest NASDAQ
Closing Price, while the number of Depositary Shares issuable upon exercise will be increased such that the aggregate exercise price of
the Series L Warrants on the issuance date for the Depositary Shares underlying the Series L Warrants then outstanding shall remain unchanged.
Subsequently, at 4:01 p.m. Eastern time on the Second Reset Date, the exercise price of the Series L Warrants will be reset to a price
equal to the lower of (i) the exercise price then in effect and (ii) the greater of (a) 80% of lowest VWAP during the period beginning
on the 8th trading day after the date of issuance and ending on the Second